Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Jan 16, 2024 (filed on Jan 18, 2024)Insider Name:Goldberger Daniel SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:75,000Price:--
-
Jan 12, 2024 (filed on Jan 17, 2024)Insider Name:Posner Brian MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:16,000Price:--
-
Jan 01, 2024 (filed on Jan 03, 2024)Insider Name:Theofilos Charles SteveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,210Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Prefunded Common Stock Warrants (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common Stock Warrants (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
Filings by filing date
-
Jan 16, 2024 (filed on Jan 18, 2024)Insider Name:Goldberger Daniel SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:75,000Price:--
-
Jan 12, 2024 (filed on Jan 17, 2024)Insider Name:Posner Brian MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:16,000Price:--
-
Jan 01, 2024 (filed on Jan 03, 2024)Insider Name:Theofilos Charles SteveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,210Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Prefunded Common Stock Warrants (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common Stock Warrants (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Dec 18, 2023 (filed on Dec 18, 2023)Insider Name:Theofilos Charles SteveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 200 FORGE WAY, SUITE 205 ROCKAWAY NJ 07866 |
Tel: | N/A |
Website: | https://www.electrocore.com |
IR: | See website |
Key People | ||
Daniel S. Goldberger Chief Executive Officer, Director | Brian M. Posner Chief Financial Officer |
Business Overview |
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company's product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company's TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition. |
Financial Overview |
For the fiscal year ended 31 December 2023, electroCore, Inc. revenues increased 87% to $16M. Net loss decreased 15% to $18.8M. Revenues reflect United States segment increase from $7M to $14.2M, United Kingdom segment increase of 21% to $1.6M. Lower net loss reflects Stock-based Compensation in SGA decrease of 38% to $1.4M (expense), Interest and other income increase of 51% to $433K (income). |
Employees: | 68 as of Feb 1, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $23.16M as of Dec 31, 2023 |
Annual revenue (TTM): | $16.03M as of Dec 31, 2023 |
EBITDA (TTM): | -$18.31M as of Dec 31, 2023 |
Net annual income (TTM): | -$18.83M as of Dec 31, 2023 |
Free cash flow (TTM): | -$14.78M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 6,002,628 as of Mar 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |